FDA Adverse Event Malfunction Summary report: N

VITALITY

MDR report key: 2780445 · Received October 10, 2012

Report

Report Number
2124215-2012-12574
Event Type
Malfunction
Date Received
October 10, 2012
Date of Event
July 6, 2011
Report Date
September 17, 2012
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A REVIEW OF DEVICE MEMORY REVEALED THAT THE DEVICE DECLARED ELECTIVE REPLACEMENT INDICATOR (ERI) AFTER EXPERIENCING TWO CONSECUTIVE CHARGE TIMES GREATER THAN THE EXTENDED MID-LIFE ERI CHARGE TIME LIMIT. THE OBSERVED RATE OF BATTERY USAGE WAS COMPARED TO THE EXPECTED RATE OF BATTERY USAGE; THE RESULTS INDICATED THAT THE MONITORING VOLTAGE WAS NORMAL. ALTHOUGH THE BATTERY ITSELF HAD NOT DEPLETED PREMATURELY, ERI WAS TRIGGERED EARLIER THAN EXPECTED BY EXTENDED CHARGE TIMES DUE TO A HIGHER-THAN-TYPICAL BUILDUP OF INTERNAL BATTERY IMPEDANCE.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT WHILE THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS IMPLANTED, IT SHOWED AN EXTENDED CHARGE TIME. THERE WAS NO ALLEGATION OF PREMATURE BATTERY DEPLETION. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) WAS CONTACTED FOR A LONGEVITY ESTIMATE AND TS RECOMMENDED TO FOLLOW THE RECOMMENDATIONS PROVIDED IN DEVICE LABELING FOR FOLLOW-UPS. NO ADVERSE PATIENT EFFECTS WERE REPORTED. OVER A YEAR LATER, THIS ICD WAS RETURNED FOR DISPOSAL ONLY, WITH NO REPORTED PRODUCT PERFORMANCE ISSUES AND NO REPORTED ADVERSE PATIENT EFFECTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITALITY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND T135

Patients

Seq Age Sex Outcome Treatment
1 88 YR T135| 0185